• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

EXPLOITATION OF NEW DIAGNO-THERAPEUTIC PROCEDURES OF HUMAN ENDOCERVICAL ADENOCARCINOMA OF THE UTERUS BASED ON CYTOGENETIC MECHANISMS OF MULTI- STEP CARCINOGENESIS

Research Project

Project/Area Number 12671643
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionJapanese Foundation for Cancer Research

Principal Investigator

HIRAI Yasuo  CANCER INSTITUTE, DEPT. OF CELL BIOLOGY, ASSOCIATE, 癌研究所・細胞生物部, 研究員 (00260076)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsENDOCERVICAL ADENQCARCINOMAS / TGF 13 RII / BAX / CHROMOSOMAL IMBALANCE / PTEN / MICROSATELLITE INSTABILITY / COMPARATIVE GENOMIC INSTABILITY / MULTISTEP CARCINOGENESIS / 子宮頚部腺癌 / TGFβRII / BAX / SMAD / CGH / 発癌過程
Research Abstract

We analysed the mutational status of the TGF β RII, BAX, and PTEN/MMAC1 genes as well as microsatellite instability (MI) in consecutive cases of endocervical adenocarcinoma of the uterus operated on at our Institute. To examine copy number losses and/or amplifications at the chromosomal region bearing all the genes, we used comparative genornic hybridization (CGH) analysis. CGH analysis may provides a genome-wide overview about tumor-associated genomic imbalances. Among the tumors, a few showed, the MI+ phenotype. Also, few tumors demonstrated a significant mutation with a definite amino acid change in PTEN/MMAC1 gene. CGH analysis demonstrated that a few tumors showed chromosomal copy number losses and/or amplifications, whereas there are no common chromosomal foci showing losses or amplifications among the tumors analysed so far. The role of TGF β RI and BAX genes may be limited as a target gene of MI+ phenotype in endocervical adenocarcinoma, because only a few tumors demonstrated MI+ phenotype in these tumors.
Additional explorations are needed to elucidate the cytogenetic mechanisms of multistep carcinogenesis in endocervical adenocarcinomas of the uterus.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (25 results)

All Other

All Publications (25 results)

  • [Publications] Hirai Y: "Scmatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomalloss detected using comparative genomic hybridization in endometrial cancer"Gynecol Oncol. 83. 81-88 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirai Y: "Malignant Potential of Positive Peritoneal Cytology in Endometrial Cancer"Gynecol Oncol. 97. 725-728 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugiyama Y, Hiral Y: "Microdissection is essential for gene expression profiling or clinically resected cancer tissues"Am J Clin Pathol. 117. 109-116 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Katase K, Hirai Y.: "Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause : a randomized placebo-controlled study"Calcif Tissue Int. 69. 73-77 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sekine M, Hiral Y: "Mutational analysis of brcal and brca2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families"Clin Cancer Res. 7. 3144-3150 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sekine M, Hirai Y: "Localization of a novel susceptibility gene for famllial ovarian cancer to chromosome 3p22-p25"Hum Mol Genet. 15. 1421-9 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirai Y, Tanaka N, Furuta R, Kawaguchi T, Sakamoot M, Shirahatma S, Noda T.: "Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer"Gynecol Oncol. 83(1). 81-8 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirai Y, Takeshima N, Kato T, Hasumi K.: "Malignant potential of positive peritoneal cytology in endometrial cancer."Obstet Gynecol. 97(5 Pt 1). 725-8 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sugiyama Y, Sugiyama K, Hirai Y, Akiyama F, Hasumi K.: "Microdissection is essential for gene expression profiling of clinically resected cancer tissues."Am J Clin Pathol.. 117(1). 109-16 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Katase K, Kato T, Hirai Y, Hasumi K, Chen JT.: "Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause : a randomized placebo-controlled study."Calcif Tissue Int.. 69(2). 73-7 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka.: "Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families : two common founder mutations of BRCA1 in Japanese population"Clin Cancer Res.. 7(10). 3144-50 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K.: "Localization of a novel susceptibility gene for familial ovarian cencer to chromosome 3p22-p25"Hum Mol Genet.. 10(13). 1421-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirai Y: "Somatic mutations of the PThN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer"Gynecol Oncol. 83. 81-8 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hirai Y: "Malignant Potential of Positive Peritoneal Cytology in Endometrial Cancer"Obstet Gynecol. 97. 725-728 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sugiyama Y, Hirai Y: "Microdissection is essential for gene expression profiling of clinically resected cancer tissues"Am J Clin Pathol. 117. 109-116 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Katase K, Hirai Y: "Effects of lpriflavone on bone loss following a bilateral ovariectomy and menopause : a randomized placebo-controlled study"Calcif Tissue Int. 69. 73-77 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sekine M, Hirai Y: "Mutational analysis of brcal and brca2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families"Clin Cancer Res. 7. 3144-3150 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sekine M, Hiral Y: "Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25"Hum Mol Genet. 15. 1421-1429 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Y Hirai,N Takeshima et al: "Malignant Potential of Positive Peritoneal Cytology in Endometrial Cancer"Obstetrics & Gynecology. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] K Matsumoto,Y Hirai et al: "Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population"Cancer Letters. 156. 159-165 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] T Tabata,Y Hirai et al: "Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma"Tumor Biology. 21. 375-380 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] K Yanoh,Y Hirai et al: "Prognostic value of the colposcopic tumor size in stage IB squamous cervical cancer"Journal of Surgical Oncology. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 平井康夫: "技術講座病理 子宮頚部細胞診の読みかた"検査と技術. 28. 1109-1114 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] K Kashima,Y Hirai et al: "Screening of BRCA1 mutation using Immunohistochemical staining with Cterminal and N-Terminal antibodies in familial ovarian cancer"Jpn.J.Cancer Reci. 91. 399-409 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 平井康夫: "IV子宮肉腫 子宮肉腫に対する化学療法.新女性医学大系"(株)中山書店 悪性腫瘍の薬物・放射線療法,(篠塚孝男 編). 233-238 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi